- Inflammatory Biomarkers in Disease Prognosis
- Intramuscular injections and effects
- COVID-19 and healthcare impacts
- COVID-19 Clinical Research Studies
- Bone and Joint Diseases
- Hematological disorders and diagnostics
- Heparin-Induced Thrombocytopenia and Thrombosis
- SARS-CoV-2 and COVID-19 Research
Sakarya Eğitim ve Araştırma Hastanesi
2024
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was first detected in December and then spread globally, resulting a pandemic. Initially, it unknown if chronic kidney (CKD) contributed to the mortality COVID-19. The immunosuppression associated with this may minimize COVID-19-described hyper-inflammatory state or immunological dysfunction, high prevalence of comorbidities lead poorer clinical prognosis. Patients COVID-19 have...
Inflammation forms the basis of cancer development and progression. It causes changes in complete blood count parameters, such as neutrophil counts. Low albumin levels are associated with poor prognosis patients. We aimed to investigate association between ratio (NAR) stage non-small cell lung (NSCLC).257 NSCLC patients (24 females 198 males) were included study. Patients divided into two groups. Group 1 (n=61) early (stage 2), while group 2 (n=196) those advanced 3 4). Demographic data,...
Aim: The aim of this study is to evaluate the sociodemographic and clinical characteristics patients with COVID-19 that developed after vaccination. Material Method: was conducted at a state hospital between July 5 August 5, 2021. Patients who received vaccine, whose SARS-CoV-2 positivity confirmed by molecular methods, were hospitalized for included. Sociodemographic information observation results recorded. Results: 49.09% female median age 72.00 [62.00-79.00] years. 70.45% had chronic...